Abstract
Xanthones or 9H-xanthen-9-ones (dibenzo-γ-pyrones) comprise an important class of oxygenated heterocycles, with prenylated derivatives being the most abundant group. The prenylated xanthones are found to possess a wide range of important biological and pharmacological activities. As a consequence of this, synthetic strategies leading to new and more complex molecules have been widely explored in the past years. In our literature survey, from January 1963 to March 2009, a total of 93 synthetic prenylated xanthones were described and 24 of them were firstly obtained from natural sources. Thus, the main purpose of this review is to report synthetic methods to obtain prenylated xanthones, such as simple prenylation, Claisen rearrangement and/or cyclization. We also discuss the application of new methodologies to the synthesis of prenylated derivatives, such as microwave assisted organic synthesis, heterogeneous catalysis with Montmorillonite K10 Clay as catalyst and the combination of heterogeneous catalysis with microwave irradiation. Furthermore, different approaches and methodologies used to synthesize bioactive natural prenylated xanthones, like α-mangostin, are also discussed. Finally, biological activities of prenylated xanthones are also briefly referred.
Current Organic Chemistry
Title: Synthesis of Prenylated Xanthones: An Overview
Volume: 13 Issue: 12
Author(s): M. M. M. Pinto and R. A. P. Castanheiro
Affiliation:
Abstract: Xanthones or 9H-xanthen-9-ones (dibenzo-γ-pyrones) comprise an important class of oxygenated heterocycles, with prenylated derivatives being the most abundant group. The prenylated xanthones are found to possess a wide range of important biological and pharmacological activities. As a consequence of this, synthetic strategies leading to new and more complex molecules have been widely explored in the past years. In our literature survey, from January 1963 to March 2009, a total of 93 synthetic prenylated xanthones were described and 24 of them were firstly obtained from natural sources. Thus, the main purpose of this review is to report synthetic methods to obtain prenylated xanthones, such as simple prenylation, Claisen rearrangement and/or cyclization. We also discuss the application of new methodologies to the synthesis of prenylated derivatives, such as microwave assisted organic synthesis, heterogeneous catalysis with Montmorillonite K10 Clay as catalyst and the combination of heterogeneous catalysis with microwave irradiation. Furthermore, different approaches and methodologies used to synthesize bioactive natural prenylated xanthones, like α-mangostin, are also discussed. Finally, biological activities of prenylated xanthones are also briefly referred.
Export Options
About this article
Cite this article as:
Pinto M. M. M. and Castanheiro A. P. R., Synthesis of Prenylated Xanthones: An Overview, Current Organic Chemistry 2009; 13 (12) . https://dx.doi.org/10.2174/138527209788921747
DOI https://dx.doi.org/10.2174/138527209788921747 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Cation-Responsive MRI Contrast Agents Based on Gadolinium(III)
Current Inorganic Chemistry (Discontinued) PET and SPECT Imaging of Tumor Biology: New Approaches Towards Oncology Drug Discovery and Development
Current Computer-Aided Drug Design Advances in Photodynamic Therapy Assisted by Electroporation
Current Drug Metabolism The Glycogen Synthase Kinase-3 in the Regulation of Ion Channels and Cellular Carriers
Current Medicinal Chemistry Electrochemical Cell-based Biosensors for Biomedical Applications
Current Topics in Medicinal Chemistry Targeting βIII-Tubulin in Glioblastoma Multiforme: From Cell Biology and Histopathology to Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Current Medicinal Chemistry Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
Current Pharmaceutical Design Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis
Current Genomics Luminescent Silica Nanoparticles for Cancer Diagnosis
Current Medicinal Chemistry Targeted Taxane Delivery Systems: Recent Advances
Drug Delivery Letters Updates of mTOR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Novel Agents in Anticancer Drug Therapy I (Antiangiogenic Agents, Egfr Inhibitors)
Medicinal Chemistry Reviews - Online (Discontinued) Arsenic Trioxide and Artemisinin Act Synergistically to Kill Tumor Cells In Vitro
Anti-Cancer Agents in Medicinal Chemistry Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling
Current Cancer Drug Targets MTHFR Gene Polymorphism and Diabetic Retinopathy
Current Diabetes Reviews Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in the Synthesis of Biologically Relevant Selenium-containing 5-Membered Heterocycles
Current Organic Chemistry Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry